After Blood Clot Reports, Some Countries Stop Using the Oxford/AstraZeneca COVID-19 Vaccine
The European Medicines Agency (EMA) held an emergency meeting on Mar. 18, 2021 after many European countries suspended use of the Oxford/AstraZeneca experimental COVID-19 vaccine due to reports of severe side effects including blood clots, low platelet counts and death.1 The EMA conducted a preliminary investigation into potential serious side effects and pronounced the vaccine […]
